| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-319-23730-5_11 |
| P698 | PubMed publication ID | 26659003 |
| P50 | author | Mary Nugent | Q57410075 |
| P2860 | cites work | Identification of Differentially Expressed MicroRNAs in Osteosarcoma | Q21296759 |
| TWIST interacts with endothelin-1/endothelin A receptor signaling in osteosarcoma cell survival against cisplatin | Q41908532 | ||
| Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells | Q42009448 | ||
| The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. | Q42084526 | ||
| Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling | Q42712813 | ||
| Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma | Q44364850 | ||
| Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols | Q44438560 | ||
| A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma | Q44481241 | ||
| Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma | Q44547830 | ||
| Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma | Q45056241 | ||
| Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone. | Q47860378 | ||
| Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression. | Q50658268 | ||
| Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma. | Q53054320 | ||
| The Biology of Ewing sarcoma. | Q53575285 | ||
| MicroRNAs and cancer. | Q53581378 | ||
| The expression and function of miRNA-451 in osteosarcoma. | Q53671699 | ||
| A causal role for circulating miR-34b in osteosarcoma. | Q54242197 | ||
| Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. | Q54243283 | ||
| Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma. | Q54253829 | ||
| Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma. | Q54275608 | ||
| High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions | Q56992193 | ||
| Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS) | Q81295341 | ||
| Risk of recurrence and survival after relapse in patients with Ewing sarcoma | Q83731173 | ||
| Diallyl trisulfide reverses drug resistance and lowers the ratio of CD133+ cells in conjunction with methotrexate in a human osteosarcoma drug-resistant cell subline | Q83811440 | ||
| Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin | Q83961794 | ||
| MicroRNA-21 is involved in osteosarcoma cell invasion and migration | Q84245716 | ||
| MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93 | Q85017897 | ||
| Giant cell tumor of bone | Q86049811 | ||
| miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy | Q87725107 | ||
| EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. | Q34283431 | ||
| Retracted: MicroRNA-217 Regulates WASF3 Expression and Suppresses Tumor Growth and Metastasis in Osteosarcoma | Q34301635 | ||
| The natural history of hereditary multiple exostoses | Q34330009 | ||
| New roles of cyclin D1. | Q34352513 | ||
| MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma | Q34570975 | ||
| Properties of the stromal cell in giant cell tumor of bone | Q34576537 | ||
| Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues | Q34734182 | ||
| Gallic acid induces apoptosis and inhibits cell migration by upregulating miR-518b in SW1353 human chondrosarcoma cells | Q35029141 | ||
| MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis | Q35082529 | ||
| MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression | Q35086698 | ||
| Differentially expressed miRNAs in Ewing sarcoma compared to mesenchymal stem cells: low miR-31 expression with effects on proliferation and invasion. | Q35131440 | ||
| Regulation of cortical actin networks in cell migration. | Q35605754 | ||
| miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. | Q35783986 | ||
| miRNA signatures associate with pathogenesis and progression of osteosarcoma | Q35894610 | ||
| MicroRNA Involvement in Osteosarcoma | Q35898407 | ||
| Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis | Q35945084 | ||
| MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma | Q36594516 | ||
| Osteosarcoma development and stem cell differentiation | Q36803600 | ||
| A microRNA DNA methylation signature for human cancer metastasis | Q36861111 | ||
| MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32. | Q36998227 | ||
| MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma | Q37175182 | ||
| MicroRNAs: key players in carcinogenesis and novel therapeutic targets. | Q37223100 | ||
| Emerging role of Notch in stem cells and cancer | Q37234117 | ||
| Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. | Q37235523 | ||
| Roles of the EZH2 histone methyltransferase in cancer epigenetics | Q37250591 | ||
| Analysis of microRNAs expressions in chondrosarcoma | Q37328637 | ||
| EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma | Q37461081 | ||
| MicroRNA function and dysregulation in bone tumors: the evidence to date | Q37473350 | ||
| MicroRNAs, ultraconserved genes and colorectal cancers | Q37508276 | ||
| miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2. | Q37535463 | ||
| Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma | Q37535484 | ||
| miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation | Q37620702 | ||
| MicroRNAs in colorectal cancer: translation of molecular biology into clinical application | Q37632608 | ||
| miRBase: microRNA sequences, targets and gene nomenclature | Q24538656 | ||
| The microRNA Registry | Q24600787 | ||
| Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis | Q24609213 | ||
| miRBase: integrating microRNA annotation and deep-sequencing data | Q24615914 | ||
| A microRNA signature for a BMP2-induced osteoblast lineage commitment program | Q24647487 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| Tumour invasion and metastasis initiated by microRNA-10b in breast cancer | Q28131829 | ||
| Post-transcriptional gene silencing by double-stranded RNA | Q28205087 | ||
| A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG | Q28252253 | ||
| miRNA-34c regulates Notch signaling during bone development | Q28264397 | ||
| HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145 | Q28284329 | ||
| MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures | Q28288937 | ||
| A microRNA component of the p53 tumour suppressor network | Q28305330 | ||
| miRBase: annotating high confidence microRNAs using deep sequencing data | Q28660701 | ||
| Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT | Q28744173 | ||
| Control of translation and mRNA degradation by miRNAs and siRNAs | Q29614239 | ||
| Many roads to maturity: microRNA biogenesis pathways and their regulation | Q29615469 | ||
| miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. | Q30407836 | ||
| What's new in primary bone tumors | Q33274602 | ||
| Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas | Q33580714 | ||
| Cross-talk between miRNA and Notch signaling pathways in tumor development and progression | Q33801752 | ||
| MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma | Q33857405 | ||
| The tumor-suppressive microRNA-135b targets c-myc in osteoscarcoma | Q33905746 | ||
| Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone | Q33913401 | ||
| Collagenase expression and activity in the stromal cells from giant cell tumour of bone. | Q33952332 | ||
| Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development | Q33997274 | ||
| The epidemiology of osteosarcoma | Q34021577 | ||
| Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response | Q34143825 | ||
| MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo | Q34211970 | ||
| Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma | Q34228576 | ||
| miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. | Q37681865 | ||
| The IGF system. | Q37806130 | ||
| Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets | Q37828406 | ||
| Rho-associated coiled-coil kinase (ROCK) signaling and disease | Q38100279 | ||
| New molecular insights into osteosarcoma targeted therapy | Q38105962 | ||
| MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. | Q38314373 | ||
| MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor | Q38321646 | ||
| Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma | Q38338166 | ||
| Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR. | Q38931801 | ||
| CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells | Q38936040 | ||
| Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements | Q38946067 | ||
| The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression | Q38947625 | ||
| MicroRNA-214 regulates osteosarcoma survival and growth by directly targeting phosphatase and tensin homolog | Q38948453 | ||
| MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells | Q38981901 | ||
| miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1. | Q38997806 | ||
| microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1. | Q38999326 | ||
| MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells | Q39022078 | ||
| MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway | Q39024985 | ||
| Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients | Q39031668 | ||
| miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells | Q39032011 | ||
| MicroRNA-320 inhibits osteosarcoma cells proliferation by directly targeting fatty acid synthase | Q39037295 | ||
| The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma | Q39041044 | ||
| MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13. | Q39041307 | ||
| Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma | Q39068017 | ||
| miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells | Q39105277 | ||
| miR-335 inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways | Q39106858 | ||
| MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. | Q39122905 | ||
| MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. | Q39140942 | ||
| MicroRNA-17-92 cluster regulates osteoblast proliferation and differentiation | Q39152048 | ||
| MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATβ. | Q39167853 | ||
| miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma | Q39178990 | ||
| MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein | Q39185667 | ||
| TWIST interacts with β-catenin signaling on osteosarcoma cell survival against cisplatin | Q39217966 | ||
| Circulating microRNAs as novel minimally invasive biomarkers for breast cancer | Q39281588 | ||
| miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells | Q39291031 | ||
| MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells | Q39312408 | ||
| Downstream EWS/FLI1 - upstream Ewing's sarcoma | Q39325942 | ||
| MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma | Q39437011 | ||
| miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. | Q39441445 | ||
| miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 | ||
| MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration | Q39526077 | ||
| MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. | Q39582762 | ||
| Circulating miR-34a levels are reduced in colorectal cancer | Q39610241 | ||
| Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis | Q39619751 | ||
| EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells | Q39716224 | ||
| Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples | Q39820788 | ||
| MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma | Q39897190 | ||
| Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase | Q39908852 | ||
| Increased Fas expression reduces the metastatic potential of human osteosarcoma cells | Q40483274 | ||
| A polymorphism site in the pre‑miR‑34a coding region reduces miR‑34a expression and promotes osteosarcoma cell proliferation and migration | Q41871223 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone cancer | Q18554919 |
| microRNA | Q310899 | ||
| P304 | page(s) | 201-230 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | microRNA and Bone Cancer | |
| P478 | volume | 889 |
| Q39319386 | Gankyrin as a potential therapeutic target for cancer |
| Q37221246 | Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma |
| Q55127822 | Inhibition of LCMR1 and ATG12 by demethylation-activated miR-570-3p is involved in the anti-metastasis effects of metformin on human osteosarcoma. |
| Q94452908 | LncRNA OR3A4 Regulated the Growth of Osteosarcoma Cells by Modulating the miR-1207-5p/G6PD Signaling |
| Q50093882 | MiR-107 suppresses cell proliferation and tube formation of Ewing sarcoma cells partly by targeting HIF-1β. |
| Q37709281 | MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein |
| Q26766383 | MicroRNA biogenesis and their functions in regulating stem cell potency and differentiation |
| Q37545109 | MicroRNA-187 exerts tumor-suppressing functions in osteosarcoma by targeting ZEB2. |
| Q50892571 | MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4. |
| Q49335091 | MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1. |
| Q92838267 | MicroRNA-451 dictates the anoikis resistance of osteosarcoma by targeting Rab14 |
| Q90465565 | MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1 |
| Q37227983 | MicroRNA-494 inhibits proliferation and metastasis of osteosarcoma through repressing insulin receptor substrate-1. |
| Q49254629 | MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion |
| Q37545114 | MicroRNA-613 suppresses proliferation, migration and invasion of osteosarcoma by targeting c-MET. |
| Q99617216 | MicroRNA-615 functions as a tumor suppressor in osteosarcoma through the suppression of HK2 |
| Q64235091 | MicroRNA-876-5p inhibits cell proliferation, migration and invasion by targeting c-Met in osteosarcoma |
| Q38673947 | MicroRNAs and Fracture Healing |
| Q39025218 | MicroRNAs in bone diseases. |
| Q94463960 | Role of cancer stem cells in the development of giant cell tumor of bone |
| Q39020213 | Small non-coding RNAs-based bone regulation and targeting therapeutic strategies. |
| Q38663477 | Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression. |
| Q97528359 | The suppressive role of miR-362-3p in epithelial ovarian cancer |
| Q55618724 | The tumor suppressor role of microRNA-338-3p in renal cell carcinoma. |
| Q90636463 | Up-Regulation of Hsa_circ_0008792 Inhibits Osteosarcoma Cell Invasion and Migration and Promotes Apoptosis by Regulating Hsa-miR-711/ZFP1 |
| Q39168132 | What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma? |
| Q38721645 | miR-214-5p Targets ROCK1 and Suppresses Proliferation and Invasion of Human Osteosarcoma Cells |
| Q47910251 | miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells |
Search more.